BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 29
• 30
• 31

• Press Releases

  CorMedix Inc. Added to Nasdaq Biotechnology Index

  December 20, 2024

   · 

  1 min read
• Press Releases

  Shuttle Pharma Enters into Sponsored Research Agreement with the University of California, San Francisco to Advance PSMA Development Program

  December 20, 2024

   · 

  4 min read
• Press Releases

  Lexaria’s Registered GLP-1 Study #4 Begins Dosing

  December 20, 2024

   · 

  6 min read
• Press Releases

  MIRA Pharmaceuticals Submits IND for Ketamir-2 to FDA, Marking a Significant Milestone in the Company’s Pipeline Development

  December 20, 2024

   · 

  6 min read
• Press Releases

  LakeShore Biopharma Reports Unaudited Financial Results for the First Half of Fiscal Year 2025 and Updates Full-Year Guidance

  December 20, 2024

   · 

  15 min read
• Press Releases

  Neogen® Announces Second-Quarter Earnings Release Date

  December 20, 2024

   · 

  1 min read
• Press Releases

  TNF Pharmaceuticals Announces Trial to Explore Effects of Lead Candidate in Sarcopenia/Frailty Induced by GLP-1 Weight Loss Drugs

  December 20, 2024

   · 

  7 min read
• Press Releases

  Omeros’ Narsoplimab Meets its Pivotal Trial Primary Endpoint – Statistical Analysis Shows Survival Superiority Over External Control in Patients with TA-TMA

  December 20, 2024

   · 

  12 min read
• Press Releases

  LimmaTech Awarded FDA Fast Track Designation for Vaccine Candidate Against Staphylococcus aureus

  December 20, 2024

   · 

  4 min read
• Press Releases

  Immix Biopharma Announces Positive U.S. Clinical Data From First Four Patients in NEXICART-2 U.S. Trial of sterically-optimized CAR-T NXC-201 in relapsed/refractory Light Chain (AL) Amyloidosis

  December 20, 2024

   · 

  10 min read